Oxford Nanopore Technologies Investor Relations Material
Latest events
H1 2024
Oxford Nanopore Technologies
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Oxford Nanopore Technologies plc
Access all reports
Segment Data
Access more data
Revenue by
Geography
Europe & U.K.
Americas
China
United Arab Emirates
Other
Expenses by
Financials
Oxford Nanopore Technologies Limited provides nanopore-based data analysis systems for biomedical and industrial applications. The company offers PromethION, a benchtop nano-sensor for human DNA and RNA sequencing; MinION, a portable device for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing; GridION, a self-contained bench top device for running and processing up to five MinION or Flongle flow cells; PromethION 24 and PromethION 48, sequencing systems for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an alternative laboratory equipment.
Key slides for Oxford Nanopore Technologies plc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Oxford Nanopore Technologies plc
H1 2024
Oxford Nanopore Technologies plc
Latest articles
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
Ticker symbol
ONT
Country
🇬🇧 United Kingdom